Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROVID-PROGRESS - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19

NCT04977934 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT04977934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04977934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROVID-PROGRESS - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Unknown status
Start date
January 20, 2021
Completion date
June 30, 2023
Enrollment
94 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia